Downregulation of myostatin pathway in neuromuscular diseases may explain challenges of anti-myostatin therapeutic approaches
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Downregulation of myostatin pathway in neuromuscular diseases may explain challenges of anti-myostatin therapeutic approaches
Authors
Keywords
-
Journal
Nature Communications
Volume 8, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-11-24
DOI
10.1038/s41467-017-01486-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Reduced serum myostatin concentrations associated with genetic muscle disease progression
- (2017) Peter M. Burch et al. JOURNAL OF NEUROLOGY
- Follistatin Gene Therapy for Sporadic Inclusion Body Myositis Improves Functional Outcomes
- (2017) Jerry R. Mendell et al. MOLECULAR THERAPY
- Activin A more prominently regulates muscle mass in primates than does GDF8
- (2017) Esther Latres et al. Nature Communications
- Sporadic inclusion body myositis: A review of recent clinical advances and current approaches to diagnosis and treatment
- (2016) Merrilee Needham et al. CLINICAL NEUROPHYSIOLOGY
- Translational Pharmacokinetic/Pharmacodynamic Analysis of MYO-029 Antibody for Muscular Dystrophy
- (2016) P Singh et al. CTS-Clinical and Translational Science
- ActRIIB blockade increases force-generating capacity and preserves energy supply in exercising mdx mouse muscle in vivo
- (2016) Nelly Béchir et al. FASEB JOURNAL
- Myostatin inhibitor ACE-031 treatment of ambulatory boys with Duchenne muscular dystrophy: Results of a randomized, placebo-controlled clinical trial
- (2016) Craig Campbell et al. MUSCLE & NERVE
- No longer going to waste
- (2016) Ken Garber NATURE BIOTECHNOLOGY
- Myasthenia Gravis
- (2016) Nils E. Gilhus NEW ENGLAND JOURNAL OF MEDICINE
- Correlation between low FAT1 expression and early affected muscle in facioscapulohumeral muscular dystrophy
- (2015) Virginie Mariot et al. ANNALS OF NEUROLOGY
- Combination Antisense Treatment for Destructive Exon Skipping of Myostatin and Open Reading Frame Rescue of Dystrophin in Neonatal mdx Mice
- (2015) Ngoc B Lu-Nguyen et al. MOLECULAR THERAPY
- A Phase 1/2a Follistatin Gene Therapy Trial for Becker Muscular Dystrophy
- (2015) Jerry R Mendell et al. MOLECULAR THERAPY
- Non-Invasive Biomarkers for Duchenne Muscular Dystrophy and Carrier Detection
- (2015) Mónica Anaya-Segura et al. MOLECULES
- Muscle wasting in disease: molecular mechanisms and promising therapies
- (2015) Shenhav Cohen et al. NATURE REVIEWS DRUG DISCOVERY
- Developmental myosins: expression patterns and functional significance
- (2015) Stefano Schiaffino et al. Skeletal Muscle
- Duchenne and Becker Muscular Dystrophies
- (2014) Kevin M. Flanigan NEUROLOGIC CLINICS
- Treatment of sporadic inclusion body myositis with bimagrumab
- (2014) A. A. Amato et al. NEUROLOGY
- Gene Therapy Prolongs Survival and Restores Function in Murine and Canine Models of Myotubular Myopathy
- (2014) M. K. Childers et al. Science Translational Medicine
- Combination of Myostatin Pathway Interference and Dystrophin Rescue Enhances Tetanic and Specific Force in Dystrophic mdx Mice
- (2010) Julie Dumonceaux et al. MOLECULAR THERAPY
- The MIQE Guidelines: Minimum Information for Publication of Quantitative Real-Time PCR Experiments
- (2009) S. A. Bustin et al. CLINICAL CHEMISTRY
- A phase I/IItrial of MYO-029 in adult subjects with muscular dystrophy
- (2008) Kathryn R. Wagner et al. ANNALS OF NEUROLOGY
- Wide ranges of serum myostatin concentrations in Duchenne muscular dystrophy patients
- (2008) Hiroyuki Awano et al. CLINICA CHIMICA ACTA
- AAV-mediated intramuscular delivery of myotubularin corrects the myotubular myopathy phenotype in targeted murine muscle and suggests a function in plasma membrane homeostasis
- (2008) Anna Buj-Bello et al. HUMAN MOLECULAR GENETICS
- Centronuclear (myotubular) myopathy
- (2008) Heinz Jungbluth et al. Orphanet Journal of Rare Diseases
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search